Passage Bio Statistics
Total Valuation
Passage Bio has a market cap or net worth of $21.75 million. The enterprise value is -$27.60 million.
Important Dates
The last earnings date was Tuesday, March 4, 2025, before market open.
Earnings Date | Mar 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Passage Bio has 62.15 million shares outstanding. The number of shares has increased by 10.34% in one year.
Current Share Class | 62.15M |
Shares Outstanding | 62.15M |
Shares Change (YoY) | +10.34% |
Shares Change (QoQ) | +0.15% |
Owned by Insiders (%) | 0.52% |
Owned by Institutions (%) | 39.52% |
Float | 48.63M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.39 |
P/TBV Ratio | 0.39 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.42.
Current Ratio | 4.07 |
Quick Ratio | 3.96 |
Debt / Equity | 0.42 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -75.07% and return on invested capital (ROIC) is -36.31%.
Return on Equity (ROE) | -75.07% |
Return on Assets (ROA) | -32.20% |
Return on Invested Capital (ROIC) | -36.31% |
Return on Capital Employed (ROCE) | -78.47% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.08M |
Employee Count | 60 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.92% in the last 52 weeks. The beta is 1.55, so Passage Bio's price volatility has been higher than the market average.
Beta (5Y) | 1.55 |
52-Week Price Change | -70.92% |
50-Day Moving Average | 0.52 |
200-Day Moving Average | 0.69 |
Relative Strength Index (RSI) | 34.47 |
Average Volume (20 Days) | 180,563 |
Short Selling Information
The latest short interest is 1.69 million, so 2.72% of the outstanding shares have been sold short.
Short Interest | 1.69M |
Short Previous Month | 1.82M |
Short % of Shares Out | 2.72% |
Short % of Float | 3.47% |
Short Ratio (days to cover) | 9.55 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -65.17M |
Pretax Income | -76.57M |
Net Income | -64.77M |
EBITDA | -62.09M |
EBIT | -65.17M |
Earnings Per Share (EPS) | -$1.07 |
Full Income Statement Balance Sheet
The company has $76.76 million in cash and $25.48 million in debt, giving a net cash position of $51.28 million or $0.83 per share.
Cash & Cash Equivalents | 76.76M |
Total Debt | 25.48M |
Net Cash | 51.28M |
Net Cash Per Share | $0.83 |
Equity (Book Value) | 61.26M |
Book Value Per Share | 0.99 |
Working Capital | 59.45M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$47.96 million and capital expenditures -$34,000, giving a free cash flow of -$47.99 million.
Operating Cash Flow | -47.96M |
Capital Expenditures | -34,000 |
Free Cash Flow | -47.99M |
FCF Per Share | -$0.77 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Passage Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.34% |
Shareholder Yield | n/a |
Earnings Yield | -273.53% |
FCF Yield | -202.67% |
Analyst Forecast
The average price target for Passage Bio is $7.67, which is 2,091.43% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $7.67 |
Price Target Difference | 2,091.43% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |